Wellbutrin SR Articles
Actavis' generic Wellbutrin and Zyban approved
7 April 2008
GSK's 1st-qtr profit continues decline
10 May 2004
Green light for 150mg Wellbutrin generics
29 March 2004
GSK results in line with company guidance; shares fall on 16% drop in 4th-qtr income
23 February 2004
Eon Labs starts shipping bupropion
26 January 2004
GSK gets boost from antidepressant ruling
29 September 2003
GSK's Wellbutrin XL on track for approval
7 July 2003
Biovail's cold sore cream cleared by FDA
13 January 2003
FDA clears new Wellbutrin SR dose
24 June 2002
Strong quarter for Canada's Biovail
6 May 2002
GSK to appeal bupropion ruling
11 March 2002
GSK reports weight loss with bupropion
4 March 2002
Biovail and GSK sign $133 million marketing deal for bupropion
29 October 2001
US HMOs reveal their most-accepted drugs
5 April 2001
GW hits Impax with bupropion lawsuits
10 October 2000
Glaxo Wellcome patent dispute with Andrx
13 September 1999
Glaxo Wellcome Calls For Injunction On Zyban Information
27 April 1998
Glaxo Wellcome 1996 Product Performance
17 March 1997
GW's Smoking Pills "OKed" In USA
23 December 1996
Glaxo Wellcome Unveils Revamped Pipeline
20 November 1995
Showing 1-22 of 22 articles
- 1
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
